Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2025-12-26 @ 2:41 AM
NCT ID:
NCT00549302
Group ID:
EG000
Title:
Tadalafil 20 mg or 40 mg Double-Blind and 40 mg Open-Label
Description:
Tadalafil 20 mg administered orally as 1 tadalafil 20-mg tablet and 1 matched placebo tablet, once daily from Day 1 up to 52 weeks of treatment, or tadalafil 40 mg (two 20-mg tablets) administered orally, once daily from Day 1 up to 52 weeks of treatment in Double-Blind Period; and tadalafil 40 mg (two 20-mg tablets) administered orally, once daily from Week 53 up to Week 243 in Open-Label Period.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
184
Serious Number At Risk:
357
Other Number Affected:
334
Other Number At Risk:
357
Study:
NCT00549302
Results Section:
NCT00549302
Adverse Events Module:
NCT00549302